MEDICILON

contact us jpkrencn

お知らせ

業界動向

あなたはここにいる:ホーム > お知らせ > 業界動向

  • 08
    07

    2015

    Biopharmas Team Up with U.K.100,000 Genomes Project

    Ten biopharma companies have joined together to create the Genomics Genomics Expert Network for Enterprises (GENE) Consortium, which will oversee a year-long trial designed to integrate industry expertise into the 100,000 Genomes Project—the U.K.’s effort to catapult itself to global leadership in genetic research into cancer and rare diseases.

  • 08
    06

    2015

    Link between Mitochondrial Protein and Heart Failure Uncovered

    While all cells in the body rely on metabolic pathways that take place within the mitochondria, the cells of some organs, such as the brain and heart, have an essential demand for constant energy. Maintaining the proper mitochondrial homeostasis is critical for overall tissue health, as defective mitochondria have been linked to a number of disease states.

  • 08
    06

    2015

    Biomolecules Sorted with Catch and Release System

    A microtubule-inspired microfluidic system that resembles a microscopic forest of arms can pluck biomolecules out of liquid mixtures, carry them from one chemical stream to another, and then release them. The system, which is dynamic and tunable, may be suitable for applications in clinical diagnostics, target characterization, environmental analysis, and chemical purification.

  • 08
    05

    2015

    Cancer Drug Spending Reaches $100B Mark

    Total global spending on cancer medicines reached the $100 billion mark last year, as patients and doctors embraced earlier diagnosis and more effective therapies requiring longer treatment durations, the IMS Institute for Healthcare Informatics said today in a report.

  • 08
    05

    2015

    Key Gene Linking Fast Acting and Slow Acting Immune Response Found

    Australian scientists say they have shown that a specific gene determines the development and function of important cells that bridge the gap between our fast-acting innate and slower-acting adaptive, immune systems.